Vaccination rates among adolescents increased significantly for hepatitis B vaccines; vaccines for varicella, tetanus, diphtheria, acellular pertussis (Td or Tdap); meningococcal conjugate vaccine (MenACWY); and human papilloma virus (HPV) vaccine, according to…
Category: News
Fear of Falling Linked to Future Falls in Elderly
Seniors who have an irrationally high fear of falling are at increased risk for future falls, irrespective of their actual physiological risk according to a new study published online today by the…
Feds to Devote New Funds to Fight Flu
The Obama administration announced that it plans to invest nearly $2 billion in measures to beef up the nation’s ability to respond to bioterrorism and pandemic threats, including $822 million for pandemic…
A Cancer Survivor Focuses on Funding Research
Roslyn and Leslie Goldstein have found that the only way to get closer to a disease’s cure is to invest in early-stage research. The couple will this month give $50,000 to underwrite…
FDA Panel Roundly Rejects CNS Drug for Fibromyalgia
A federal advisory panel voted 20-2 to recommend that the FDA not grant approval for an expanded indication for sodium oxybate (Xyrem) — also known as GHB — to treat fibromyalgia. A…
Bolder BioTechnology receives $600,000 NIH SBIR grant to study long-acting IL-11 analog in ARS
Bolder BioTechnology, Inc. today announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant totaling $600,000 from the National Institute of Allergy and Infectious Diseases (NIAID) of…
Silence Therapeutics announces partner Quark’s option agreement with Novartis for QPI-1002 siRNA drug
Silence Therapeutics plc (AIM: SLN), a leading international RNAi therapeutics company, is pleased to note that its partner, Quark Pharmaceuticals, Inc. (“Quark”), has announced the grant of an option to Novartis to…
No deportation for expats with hepatitis
New expatriate workers who are found to have Hepatitis B when they undergo their medical test will not be deported but will be given treatment, according to the Ministry of Health. Resident…
The Accuracy Of Personal Breathalyzers
Lifeloc Technologies, Inc., a leading manufacturer of professional breathalyzers has released the industry’s first independent report on the accuracy and reliability of popular semiconductor (silicone oxide) breath testers sold in mass retail,…
Air Cleaning Paving Slabs To Be Introduced In Germany
The concentrations of toxic nitrogen oxide that are present in German cities regularly exceed the maximum permitted levels. That’s now about to change, as innovative paving slabs that will help protect the…
NHS Choices: Illegal Drugs – Who’s Doing What?
Illegal drugs are responsible for up to 1,600 deaths a year in the UK, and destroy thousands of relationships, families and careers. Find out about the most commonly used illegal drugs in…
Salmonella cases are up in Texas, but link to recalled eggs unclear
Texas has been hit with a fourfold increase in salmonella infections this summer, but state and local health officials can’t say if the illnesses are related to a recent recall of tainted…
Experts Call For End To Global Inequalities In Access To Pain Medication For Cancer Sufferers
International leaders in the fight against cancer launched the Global Access to Pain Relief Initiative (GAPRI), calling for universal access to controlled pain medication for cancer patients worldwide. Action is needed now…
Lilly Moves Closer to Approval to Market Cymbalta for Chronic Pain
A federal panel on Thursday voted narrowly to recommend allowing Eli Lilly to market its blockbuster antidepressant Cymbalta for some chronic pain conditions like lower back ailments that affect millions of Americans….
Potential lupus drug gets FDA priority review
Regulators should reach a decision by early December on an experimental lupus drug made by Human Genome Sciences and GlaxoSmithKline, the companies said Thursday. The Food and Drug Administration is conducting a…